WeTrials shared a post on LinkedIn:
“Understanding Leptomeningeal Metastatic Disease (LMD)
In this video, Dr. Alireza Mansouri’s AI avatar explains how LMD develops, how it’s diagnosed, and the promising treatments and clinical trials shaping care in 2025.
At WeTrials, we believe knowledge and access can change outcomes. That’s why we’ve built the Clinical Trial Finder—to help patients and caregivers explore treatment options and ongoing research with ease.
Watch the video.
Scan the QR code at the end to explore trials personalized to you.
Feeling stuck?
Explore the resources, find community, and take empowered next steps.”
More posts featuring WeTrials on OncoDaily.